Clinical trial
Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus…
NCT00469781 · Center For Excellence In Eye Care, Other · Completed
Key facts
| NCT number | NCT00469781 |
|---|---|
| Title | Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening |
| Lead sponsor | Center For Excellence In Eye Care, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cystoid Macular Edema, Retinal Thickening |
| Intervention type | Drug |
| Interventions | 2. Xibrom (Bromfenac), 1. Pred Forte |
| Enrollment | 95 |
| Start date | May 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | May 7, 2007 |
| Last update posted | Sep 25, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: